Most Recent
The Star loses bid to recover COVID-19 losses from insurers
The Star Entertainment Group will not be able to recoup losses at its casinos and hotels stemming from the COVID-19 pandemic, after a judge found the company's $4 billion industrial special risks policy did not cover financial losses from government-imposed restrictions.
Funder wants Full Court to throw out landmark class action ruling
The funder backing a class action accusing two energy generators of gaming Queensland's energy prices wants the Full Court to find the landmark Brookfield Multiplex ruling, which held that a litigation funding arrangement for a class action was a managed investment scheme, was wrongly decided.
Crown chair, CEO to step down as royal commissioner considers new casino operator
Crown Resorts chair Helen Coonan and the CEO of Crown Melbourne will step down at the end of this month, the latest heads to roll as the casino operator attempts to persuade Royal Commissioner Ray Finkelstein QC that it should keep its Victorian licence.
Insurers’ challenge to COVID-19 business interruption claims rejected by High Court
The High Court has rejected a bid by a group of insurers to weigh in on a test case against COVID-19 related claims in business interruption policies, following a high stakes loss in the NSW Court of Appeal, which found an infectious disease exclusion did not apply.
JPMorgan wants to have its cake and eat it too in ANZ cartel case, court hears
Whistleblower JPMorgan can't be a witness in a criminal cartel case over a $2.5 billion ANZ share placement that has ensnared several investment banks and top executives and claim privilege over witness statements relevant to the case, a court has heard.
Court to hear another COVID-19 business interruption test case
A group representing insurers has filed another test case over pandemic coverage in business interruption policies, following a landmark loss in a test case concerning an infectious disease exclusion that could cost insurers $10 billion.
Full Court hears government’s $325M fight with Sanofi over ban on Plavix generic
Pharmaceutical companies Sanofi and Bristol-Myers Squibb are liable for losses to the federal government for excess subsidies it allegedly paid for the blood-thinner Plavix after an unjustified court injunction prevented the release of a generic version of the top-selling drug, an appeals court has heard.
The top litigation law firms of 2020
Lawyerly's Litigation Firms of 2020 delivered significant victories for clients last year in bet-the-company matters, thriving in a tumultuous year that saw courts and litigants adapt to virtual trials and other new norms that are sure to outlast the COVID-19 pandemic.
Law firms circle insurers over COVID-19 business interruption claims
At least five law firms are investigating lawsuits, including class action proceedings, in the wake of a landmark test case on COVID-19 exclusions for business interruption cover.
GetSwift’s move to Canada wins court, FIRB approval after fierce opposition by ASIC
Last-mile logistics software company GetSwift has ceased trading on the ASX after its relocation to Canada got the greenlight by the Federal Court and FIRB despite the company facing ongoing litigation in Australia.